Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Feng Zhang, Xiaoyong Lei & Xiaoyan Yang. (2023) Emerging roles of ncRNAs regulating ABCC1 on chemotherapy resistance of cancer – a review. Journal of Chemotherapy 0:0, pages 1-10.
Read now
Read now
Dongdong Xue, Jingzhao Han, Ze Liang, Lin Jia, Yifan Liu, Hongfang Tuo & Yanhui Peng. (2022) Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 9, pages 99-112.
Read now
Read now
Weiran Zhang, Cheng Cao, Jingfu Shen, Shaoyin Shan, Yuanhao Tong, Hongyan Cai, Zhifeng Han & Huiping Chai. (2022) Long non-coding RNA LINC01270 is an onco-promotor in lung adenocarcinoma by upregulating LARP1 via sponging miR-326. Bioengineered 13:6, pages 14472-14488.
Read now
Read now
Yu Wang, Yingying Wang, Zhiyuan Qin, Sheng Cai, Lushan Yu, Haihong Hu & Su Zeng. (2021) The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Expert Opinion on Drug Metabolism & Toxicology 17:3, pages 291-306.
Read now
Read now
Yao-Jie Pan, Jian Wan & Chun-Bin Wang. (2019) MiR-326: Promising Biomarker for Cancer. Cancer Management and Research 11, pages 10411-10418.
Read now
Read now
Weihua Zhang, Jun Lin, Peng Wang & Jian Sun. (2017) miR-17-5p down-regulation contributes to erlotinib resistance in non-small cell lung cancer cells. Journal of Drug Targeting 25:2, pages 125-131.
Read now
Read now
Takeshi Hirota, Toshihiro Tanaka, Hiroaki Takesue & Ichiro Ieiri. (2017) Epigenetic regulation of drug transporter expression in human tissues. Expert Opinion on Drug Metabolism & Toxicology 13:1, pages 19-30.
Read now
Read now
Elena Arrigoni, Sara Galimberti, Mario Petrini, Romano Danesi & Antonello Di Paolo. (2016) ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview. Expert Opinion on Drug Metabolism & Toxicology 12:12, pages 1419-1432.
Read now
Read now
Yanliang Li, Yongsheng Gao, Yue Xu, Heng Ma & Mingshan Yang. (2015) Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer. Growth Factors 33:4, pages 267-274.
Read now
Read now
Articles from other publishers (37)
Xiangguo Cui, Yu Chen, Lanqing Zhao & Xiaoxu Ding. (2023) Extracellular vesicles derived from paclitaxel-sensitive nasopharyngeal carcinoma cells deliver miR-183-5p and impart paclitaxel sensitivity through a mechanism involving P-gp. Cell Biology and Toxicology 39:6, pages 2953-2970.
Crossref
Crossref
Audrey Marjamaa, Bettine Gibbs, Chloe Kotrba & Chioniso Patience Masamha. (2023) The role and impact of alternative polyadenylation and miRNA regulation on the expression of the multidrug resistance-associated protein 1 (MRP-1/ABCC1) in epithelial ovarian cancer. Scientific Reports 13:1.
Crossref
Crossref
Yi Lv & Xiujuan Sun. (2023)
Role of
miRNA
in pathogenesis, diagnosis, and prognosis in hepatocellular carcinoma
. Chemical Biology & Drug Design.
Crossref
Crossref
Mei-Juan Tu & Ai-Ming Yu. (2023) Recent Advances in Novel Recombinant RNAs for Studying Post-transcriptional
Gene Regulation in Drug Metabolism and Disposition. Current Drug Metabolism 24:3, pages 175-189.
Crossref
Crossref
Farbod Bahreini & Nima Rezaei. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
39
.
Huoshun Shi, Lebo Sun, Dawei Zheng, Guodong Xu & Guofeng Shao. (2022) Long Noncoding RNA HLA Complex Group 18 Improves the Cell Proliferation of Myocardial Fibroblasts by Regulating the Hsa-microRNA-133a/Epidermal Growth Factor Receptor Axis. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-8.
Crossref
Crossref
Hesham A. El-Mahdy, Al-Aliaa M. Sallam, Ahmed Ismail, Samy Y. Elkhawaga, Mahmoud A. Elrebehy & Ahmed S. Doghish. (2022) miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. Pathology - Research and Practice 233, pages 153886.
Crossref
Crossref
Lucia Pavlíková, Mário Šereš, Albert Breier & Zdena Sulová. (2022) The Roles of microRNAs in Cancer Multidrug Resistance. Cancers 14:4, pages 1090.
Crossref
Crossref
Xu-feng Xu, Xiao-ke Yang, Yang Song, Bang-jie Chen, Xiao Yu, Tao Xu & Zhao-lin Chen. (2022) Dysregulation of non-coding RNAs mediates cisplatin resistance in hepatocellular carcinoma and therapeutic strategies. Pharmacological Research 176, pages 105906.
Crossref
Crossref
Yoon-Jee Chae, Ji-Eun Chang, Mi-Kyung Lee, Juhee Lim, Kwang-Hee Shin & Kyeong-Ryoon Lee. (2021) Regulation of drug transporters by microRNA and implications in disease treatment. Journal of Pharmaceutical Investigation 52:1, pages 23-47.
Crossref
Crossref
Kondapalli N. Babu & Sreenivasulu Kilari. 2022. Role of MicroRNAs in Cancers. Role of MicroRNAs in Cancers
133
148
.
DKV Prasad & Pinninti Santosh Sushma. 2022. Role of MicroRNAs in Cancers. Role of MicroRNAs in Cancers
1
12
.
Priya Mondal & Syed Musthapa Meeran. (2021) microRNAs in cancer chemoresistance: The sword and the shield. Non-coding RNA Research 6:4, pages 200-210.
Crossref
Crossref
Kimberley M. Hanssen, Michelle Haber & Jamie I. Fletcher. (2021) Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition. Drug Resistance Updates 59, pages 100795.
Crossref
Crossref
Shilpi Singh, Waseem Raza, Shahnaz Parveen, Abha Meena & Suaib Luqman. (2021) Flavonoid display ability to target microRNAs in cancer pathogenesis. Biochemical Pharmacology 189, pages 114409.
Crossref
Crossref
Luciano Pirola, Oskar Ciesielski, Marta Biesiekierska & Aneta Balcerczyk. 2021. Medical Epigenetics. Medical Epigenetics
721
740
.
Majid Ghayour-Mobarhan, Amir Sadra Zangouei, Seyed Mohammad Hosseinirad, Majid Mojarrad & Meysam Moghbeli. (2020) Genetics of blood malignancies among Iranian population: an overview. Diagnostic Pathology 15:1.
Crossref
Crossref
Kyoko Oura, Asahiro Morishita & Tsutomu Masaki. (2020) Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma—A Review. International Journal of Molecular Sciences 21:21, pages 8362.
Crossref
Crossref
Yuehui Liang, Qi Liang, Liang Qiao & Fang Xiao. (2020) MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma. Frontiers in Oncology 10.
Crossref
Crossref
Hong CheHong DingXizhen Jia. (2020)
circ_0080145 Enhances Imatinib Resistance of Chronic Myeloid Leukemia by Regulating miR-326/
PPFIA1
Axis
. Cancer Biotherapy and Radiopharmaceuticals.
Crossref
Crossref
Oliver Bruhn, Marie Lindsay, Friederike Wiebel, Meike Kaehler, Inga Nagel, Ruwen Böhm, Christian Röder & Ingolf Cascorbi. (2020) Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA Regulation. Molecular Pharmacology 97:2, pages 112-122.
Crossref
Crossref
Jose J.G. Marin, Rocio I.R. Macias, Elisa Herraez, Elisa Lozano, Marta R. Romero, Silvia Di Giacomo, Thomas Efferth & Oscar Briz. 2020. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy
197
250
.
Hyun Ah Seo, Sokviseth Moeng, Seokmin Sim, Hyo Jeong Kuh, Soo Young Choi & Jong Kook Park. (2019) MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies. Cells 9:1, pages 29.
Crossref
Crossref
Wengong Si, Jiaying Shen, Huilin Zheng & Weimin Fan. (2019) The role and mechanisms of action of microRNAs in cancer drug resistance. Clinical Epigenetics 11:1.
Crossref
Crossref
Ling Wei, Xingwu Wang, Liyan Lv, Jibing Liu, Huaixin Xing, Yemei Song, Mengyu Xie, Tianshui Lei, Nasha Zhang & Ming Yang. (2019) The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Molecular Cancer 18:1.
Crossref
Crossref
Golamreza Jadideslam, Khalil Ansarin, Ebrahim Sakhinia, Zohreh Babaloo, Alireza Abhari, Kazem Ghahremanzadeh, Mohamadreza Khalili, Rahman Radmehr & Alireza Kabbazi. (2019) Diagnostic biomarker and therapeutic target applications of miR‐326 in cancers: A systematic review. Journal of Cellular Physiology 234:12, pages 21560-21574.
Crossref
Crossref
María Paula Ceballos, Juan Pablo Rigalli, Lucila Inés Ceré, Mariana Semeniuk, Viviana Alicia Catania & María Laura Ruiz. (2019) ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma. Current Medicinal Chemistry 26:7, pages 1224-1250.
Crossref
Crossref
María V Espelt, María L Bacigalupo, Pablo Carabias & María F Troncoso. (2019) MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma. World Journal of Hepatology 11:4, pages 344-358.
Crossref
Crossref
Xiaopeng Wen, Kazumi Iwata, Keiko Ikuta, Xueqing Zhang, Kai Zhu, Masakazu Ibi, Misaki Matsumoto, Nozomi Asaoka, Junjie Liu, Masato Katsuyama & Chihiro Yabe‐Nishimura. (2019)
NOX
1/
NADPH
oxidase regulates the expression of multidrug resistance‐associated protein 1 and maintains intracellular glutathione levels
. The FEBS Journal 286:4, pages 678-687.
Crossref
Crossref
Yaomin Li, Yawei Liu, Jing Ren, Shengze Deng, Guozhong Yi, Manlan Guo, Songren Shu, Liang Zhao, Yuping Peng & Songtao Qi. (2018) miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma. Journal of Neuro-Oncology 138:3, pages 499-508.
Crossref
Crossref
Yang Zhao, Jing Chen, Wenxin Wei, Xinming Qi, Chunzhu Li & Jin Ren. (2018) The dual-inhibitory effect of miR-338-5p on the multidrug resistance and cell growth of hepatocellular carcinoma. Signal Transduction and Targeted Therapy 3:1.
Crossref
Crossref
P. Jungsuwadee & M. Vore. 2018. Comprehensive Toxicology. Comprehensive Toxicology
617
666
.
Xia Pan, Xiaoyan Yang, Jinglei Zang, Si Zhang, Nan Huang, Xinxin Guan, Jianhua Zhang, Zhihui Wang, Xi Li & Xiaoyong Lei. (2017) Downregulation of eIF4G by microRNA-503 enhances drug sensitivity of MCF-7/ADR cells through suppressing the expression of ABC transport proteins. Oncology Letters 13:6, pages 4785-4793.
Crossref
Crossref
Man Gao, Lingling Miao, Mingxia Liu, Chenggang Li, Cunzhi Yu, Hong Yan, Yongxiang Yin, Yizheng Wang, Xinming Qi & Jin Ren. (2016) miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1. Oncotarget 7:37, pages 59714-59726.
Crossref
Crossref
Zahra Salehi, Arshad Hosseini, Mohammad Najafi, Hussain Ahmad & Mohammad Reza Fayazi. (2016) Analysis of the Potential Associations of Two Common Polymorphisms in the ABCC1 Three Prime Untranslated Region With Breast Cancer Susceptibility. Thrita 5:2.
Crossref
Crossref
Ying-Jie Yi, Xiu-Hong Jia, Jian-Yong Wang, You-Jie Li, Hong Wang & Shu-Yang Xie. (2016) Knockdown of HOXA10 reverses the multidrug resistance of human chronic mylogenous leukemia K562/ADM�cells by downregulating P-gp and MRP-1. International Journal of Molecular Medicine.
Crossref
Crossref
A.-M. Yu, Y. Tian, M.-J. Tu, P. Y. Ho & J. L. Jilek. (2015) MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy. Drug Metabolism and Disposition 44:3, pages 308-319.
Crossref
Crossref